AbbVie Total Revenue from 2010 to 2025

ABBV Stock  USD 210.01  1.95  0.92%   
AbbVie Total Revenue yearly trend continues to be fairly stable with very little volatility. Total Revenue will likely drop to about 35.6 B in 2025. Total Revenue is the total amount of income generated by the sale of goods or services related to AbbVie's primary operations. View All Fundamentals
 
Total Revenue  
First Reported
2010-12-31
Previous Quarter
14.5 B
Current Value
15.1 B
Quarterly Volatility
B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check AbbVie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AbbVie's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.8 B, Interest Expense of 2.9 B or Selling General Administrative of 8.3 B, as well as many indicators such as Price To Sales Ratio of 3.46, Dividend Yield of 0.0288 or PTB Ratio of 99.06. AbbVie financial statements analysis is a perfect complement when working with AbbVie Valuation or Volatility modules.
  
Check out the analysis of AbbVie Correlation against competitors.

Latest AbbVie's Total Revenue Growth Pattern

Below is the plot of the Total Revenue of AbbVie Inc over the last few years. Total revenue comprises all receipts AbbVie Inc generated from the sale of its products or services. It is the total amount of income generated by the sale of goods or services related to the company's primary operations. AbbVie's Total Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AbbVie's overall financial position and show how it may be relating to other accounts over time.
Total Revenue10 Years Trend
Slightly volatile
   Total Revenue   
       Timeline  

AbbVie Total Revenue Regression Statistics

Arithmetic Mean33,614,398,491
Geometric Mean30,287,177,744
Coefficient Of Variation46.66
Mean Deviation13,077,979,739
Median32,753,000,000
Standard Deviation15,684,557,994
Sample Variance246005359.5T
Range43.8B
R-Value0.88
Mean Square Error59561045.3T
R-Squared0.77
Slope2,898,389,897
Total Sum of Squares3690080391.8T

AbbVie Total Revenue History

202535.6 B
202456.3 B
202354.3 B
202258.1 B
202156.2 B
202045.8 B
201933.3 B

About AbbVie Financial Statements

AbbVie investors use historical fundamental indicators, such as AbbVie's Total Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in AbbVie. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue56.3 B35.6 B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for AbbVie Stock Analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.